These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928 [TBL] [Abstract][Full Text] [Related]
5. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857 [TBL] [Abstract][Full Text] [Related]
6. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557 [TBL] [Abstract][Full Text] [Related]
7. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476 [TBL] [Abstract][Full Text] [Related]
8. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma. Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831 [TBL] [Abstract][Full Text] [Related]
9. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance]. Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417 [TBL] [Abstract][Full Text] [Related]
10. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648 [TBL] [Abstract][Full Text] [Related]
11. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B Sci Rep; 2013; 3():1400. PubMed ID: 23466598 [TBL] [Abstract][Full Text] [Related]
13. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma. Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312 [TBL] [Abstract][Full Text] [Related]
14. SOX11, a key oncogenic factor in mantle cell lymphoma. Beekman R; Amador V; Campo E Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333 [TBL] [Abstract][Full Text] [Related]
15. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749 [TBL] [Abstract][Full Text] [Related]
16. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma. He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407 [TBL] [Abstract][Full Text] [Related]
17. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas. Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745 [TBL] [Abstract][Full Text] [Related]
18. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma. He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825 [TBL] [Abstract][Full Text] [Related]
19. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma. Beà S; Amador V Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437 [TBL] [Abstract][Full Text] [Related]
20. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]